 Emily DeBoer
Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deglutition Disorders | 7 | 2025 | 148 | 2.420 |
Why?
| | Bronchiectasis | 5 | 2024 | 111 | 2.350 |
Why?
| | Down Syndrome | 6 | 2025 | 484 | 2.210 |
Why?
| | Esophageal Atresia | 4 | 2022 | 26 | 2.070 |
Why?
| | Tracheoesophageal Fistula | 4 | 2022 | 33 | 2.050 |
Why?
| | Lung Diseases, Interstitial | 7 | 2024 | 651 | 1.870 |
Why?
| | Bronchoscopy | 8 | 2021 | 225 | 1.600 |
Why?
| | Cystic Fibrosis | 7 | 2022 | 1102 | 1.380 |
Why?
| | Oscillometry | 2 | 2025 | 36 | 1.080 |
Why?
| | Child | 35 | 2025 | 21921 | 1.060 |
Why?
| | Tomography, X-Ray Computed | 9 | 2024 | 2698 | 1.030 |
Why?
| | Computer Simulation | 3 | 2021 | 996 | 1.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2019 | 649 | 1.010 |
Why?
| | Proteomics | 5 | 2023 | 1110 | 0.950 |
Why?
| | Airway Resistance | 2 | 2025 | 41 | 0.930 |
Why?
| | Lung | 12 | 2025 | 4106 | 0.900 |
Why?
| | Idiopathic Pulmonary Fibrosis | 4 | 2024 | 657 | 0.840 |
Why?
| | Delphi Technique | 2 | 2024 | 289 | 0.790 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2023 | 131 | 0.780 |
Why?
| | Airway Obstruction | 2 | 2021 | 164 | 0.770 |
Why?
| | Resilience, Psychological | 1 | 2024 | 127 | 0.760 |
Why?
| | Lung Diseases | 2 | 2020 | 785 | 0.740 |
Why?
| | Respiration Disorders | 2 | 2020 | 78 | 0.710 |
Why?
| | Hydrodynamics | 1 | 2021 | 45 | 0.700 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2021 | 44 | 0.690 |
Why?
| | Protein C | 1 | 2021 | 53 | 0.680 |
Why?
| | Burnout, Professional | 2 | 2024 | 448 | 0.670 |
Why?
| | Deglutition | 5 | 2025 | 71 | 0.660 |
Why?
| | Heart Diseases | 1 | 2023 | 335 | 0.630 |
Why?
| | Autoimmune Diseases | 1 | 2024 | 454 | 0.630 |
Why?
| | Intellectual Disability | 1 | 2021 | 168 | 0.620 |
Why?
| | Gastrointestinal Diseases | 2 | 2018 | 206 | 0.620 |
Why?
| | Tomography | 2 | 2021 | 43 | 0.600 |
Why?
| | Models, Anatomic | 2 | 2020 | 84 | 0.600 |
Why?
| | Child, Preschool | 16 | 2025 | 11158 | 0.590 |
Why?
| | Air | 1 | 2018 | 43 | 0.570 |
Why?
| | Vascular Diseases | 1 | 2020 | 240 | 0.560 |
Why?
| | Health Status | 1 | 2023 | 819 | 0.560 |
Why?
| | Aptamers, Nucleotide | 1 | 2019 | 83 | 0.550 |
Why?
| | Humans | 50 | 2025 | 138651 | 0.550 |
Why?
| | Respiration | 1 | 2018 | 207 | 0.540 |
Why?
| | Trachea | 4 | 2020 | 255 | 0.530 |
Why?
| | Sleep Wake Disorders | 1 | 2020 | 301 | 0.520 |
Why?
| | Infant | 12 | 2021 | 9574 | 0.490 |
Why?
| | Pneumonia | 1 | 2021 | 644 | 0.460 |
Why?
| | Tracheomalacia | 3 | 2020 | 17 | 0.460 |
Why?
| | Bronchi | 1 | 2015 | 269 | 0.430 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 748 | 0.420 |
Why?
| | Automation | 1 | 2014 | 99 | 0.420 |
Why?
| | Models, Biological | 1 | 2021 | 1806 | 0.420 |
Why?
| | Gastroesophageal Reflux | 2 | 2015 | 242 | 0.410 |
Why?
| | Respiratory Tract Diseases | 3 | 2019 | 181 | 0.390 |
Why?
| | Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2012 | 5 | 0.370 |
Why?
| | Retrospective Studies | 14 | 2022 | 15909 | 0.370 |
Why?
| | Hypertension, Pulmonary | 1 | 2023 | 1924 | 0.360 |
Why?
| | Esophagoscopy | 3 | 2019 | 210 | 0.360 |
Why?
| | Models, Statistical | 1 | 2015 | 663 | 0.360 |
Why?
| | Twins, Monozygotic | 1 | 2012 | 189 | 0.350 |
Why?
| | Diseases in Twins | 1 | 2012 | 159 | 0.350 |
Why?
| | Family Health | 1 | 2012 | 194 | 0.340 |
Why?
| | Magnetic Resonance Imaging | 1 | 2023 | 3637 | 0.340 |
Why?
| | Male | 22 | 2025 | 68260 | 0.330 |
Why?
| | Patient Readmission | 1 | 2016 | 703 | 0.330 |
Why?
| | Electric Impedance | 3 | 2021 | 111 | 0.320 |
Why?
| | Female | 22 | 2025 | 73763 | 0.320 |
Why?
| | Adolescent | 14 | 2025 | 21564 | 0.320 |
Why?
| | Referral and Consultation | 1 | 2015 | 793 | 0.320 |
Why?
| | Consensus | 2 | 2024 | 685 | 0.300 |
Why?
| | Asthma | 1 | 2021 | 1888 | 0.300 |
Why?
| | Neuroendocrine Cells | 2 | 2019 | 33 | 0.300 |
Why?
| | Eosinophilic Esophagitis | 3 | 2019 | 325 | 0.290 |
Why?
| | Thoracoscopy | 2 | 2019 | 58 | 0.290 |
Why?
| | Respiratory Function Tests | 2 | 2025 | 561 | 0.290 |
Why?
| | Electronic Health Records | 1 | 2016 | 1092 | 0.280 |
Why?
| | Internship and Residency | 1 | 2018 | 1187 | 0.280 |
Why?
| | Case-Control Studies | 3 | 2019 | 3523 | 0.250 |
Why?
| | Patient Care Team | 2 | 2024 | 647 | 0.250 |
Why?
| | Prospective Studies | 4 | 2025 | 7554 | 0.230 |
Why?
| | Albuterol | 1 | 2025 | 74 | 0.220 |
Why?
| | Heart Defects, Congenital | 2 | 2025 | 863 | 0.220 |
Why?
| | Young Adult | 6 | 2023 | 13305 | 0.220 |
Why?
| | Postoperative Complications | 1 | 2016 | 2722 | 0.210 |
Why?
| | Respiratory Rate | 1 | 2023 | 20 | 0.210 |
Why?
| | Gastroenterology | 2 | 2023 | 177 | 0.200 |
Why?
| | Disease Progression | 4 | 2024 | 2749 | 0.200 |
Why?
| | Vital Capacity | 3 | 2024 | 312 | 0.190 |
Why?
| | Hyperplasia | 2 | 2019 | 176 | 0.190 |
Why?
| | Respiratory System Agents | 1 | 2022 | 23 | 0.180 |
Why?
| | Aspergillosis, Allergic Bronchopulmonary | 1 | 2021 | 11 | 0.180 |
Why?
| | Pediatricians | 1 | 2023 | 129 | 0.180 |
Why?
| | Insufflation | 1 | 2021 | 13 | 0.180 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2024 | 230 | 0.180 |
Why?
| | Spinal Muscular Atrophies of Childhood | 1 | 2021 | 18 | 0.180 |
Why?
| | Medicine | 1 | 2023 | 125 | 0.180 |
Why?
| | Laryngoscopy | 2 | 2020 | 113 | 0.180 |
Why?
| | Prognosis | 2 | 2024 | 3984 | 0.170 |
Why?
| | Job Satisfaction | 1 | 2023 | 218 | 0.170 |
Why?
| | Pulmonary Ventilation | 1 | 2021 | 84 | 0.170 |
Why?
| | Indoles | 1 | 2024 | 414 | 0.170 |
Why?
| | Surface-Active Agents | 1 | 2021 | 92 | 0.170 |
Why?
| | Spirometry | 1 | 2021 | 263 | 0.170 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2025 | 310 | 0.170 |
Why?
| | Bronchodilator Agents | 1 | 2021 | 197 | 0.160 |
Why?
| | Aminophenols | 1 | 2022 | 158 | 0.160 |
Why?
| | Laryngoscopes | 1 | 2020 | 38 | 0.160 |
Why?
| | Adult | 6 | 2024 | 38201 | 0.160 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 5520 | 0.160 |
Why?
| | Heart | 1 | 2023 | 611 | 0.150 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2019 | 16 | 0.150 |
Why?
| | Digestive System Diseases | 1 | 2019 | 26 | 0.150 |
Why?
| | Ultrasonography | 1 | 2023 | 745 | 0.150 |
Why?
| | Esophageal pH Monitoring | 1 | 2018 | 23 | 0.150 |
Why?
| | Comorbidity | 2 | 2020 | 1656 | 0.150 |
Why?
| | Equipment Design | 1 | 2020 | 519 | 0.150 |
Why?
| | Formative Feedback | 1 | 2018 | 28 | 0.140 |
Why?
| | Esophageal Mucosa | 1 | 2018 | 22 | 0.140 |
Why?
| | Bronchiolitis Obliterans | 1 | 2018 | 65 | 0.140 |
Why?
| | Virtual Reality | 1 | 2019 | 65 | 0.140 |
Why?
| | Sleep | 1 | 2024 | 799 | 0.140 |
Why?
| | Diet | 1 | 2025 | 1269 | 0.130 |
Why?
| | Caregivers | 1 | 2025 | 904 | 0.130 |
Why?
| | Biomarkers | 2 | 2019 | 4092 | 0.130 |
Why?
| | Phenotype | 1 | 2025 | 3139 | 0.130 |
Why?
| | Gastrostomy | 1 | 2018 | 118 | 0.130 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 245 | 0.120 |
Why?
| | Hospitals, Pediatric | 2 | 2019 | 516 | 0.120 |
Why?
| | Pediatrics | 1 | 2024 | 1078 | 0.120 |
Why?
| | Patient-Centered Care | 1 | 2021 | 539 | 0.120 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2019 | 282 | 0.120 |
Why?
| | Program Development | 1 | 2018 | 361 | 0.120 |
Why?
| | Respiration, Artificial | 1 | 2020 | 670 | 0.120 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1482 | 0.120 |
Why?
| | Principal Component Analysis | 1 | 2015 | 193 | 0.120 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2015 | 34 | 0.110 |
Why?
| | Patient Satisfaction | 2 | 2019 | 688 | 0.110 |
Why?
| | Demography | 1 | 2015 | 296 | 0.110 |
Why?
| | Long-Term Care | 1 | 2015 | 105 | 0.110 |
Why?
| | Anesthesia | 1 | 2018 | 245 | 0.110 |
Why?
| | Imaging, Three-Dimensional | 1 | 2018 | 564 | 0.110 |
Why?
| | Larynx | 1 | 2014 | 62 | 0.110 |
Why?
| | Diagnostic Imaging | 1 | 2016 | 320 | 0.110 |
Why?
| | ROC Curve | 1 | 2015 | 562 | 0.110 |
Why?
| | Congenital Abnormalities | 1 | 2014 | 93 | 0.100 |
Why?
| | United States | 3 | 2023 | 14938 | 0.100 |
Why?
| | Inflammation | 2 | 2022 | 2850 | 0.100 |
Why?
| | Mutation | 2 | 2022 | 3987 | 0.100 |
Why?
| | Ambulatory Care | 1 | 2018 | 575 | 0.100 |
Why?
| | Infant, Newborn | 4 | 2020 | 6144 | 0.100 |
Why?
| | Quality of Life | 1 | 2025 | 2954 | 0.100 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3307 | 0.100 |
Why?
| | Pandemics | 1 | 2020 | 1641 | 0.090 |
Why?
| | Genes, Recessive | 1 | 2012 | 78 | 0.090 |
Why?
| | Fatal Outcome | 1 | 2012 | 309 | 0.090 |
Why?
| | Fibrosis | 2 | 2024 | 539 | 0.080 |
Why?
| | Logistic Models | 1 | 2015 | 2065 | 0.080 |
Why?
| | Clinical Competence | 1 | 2018 | 1149 | 0.080 |
Why?
| | Endoscopy, Digestive System | 2 | 2024 | 135 | 0.080 |
Why?
| | Intestinal Mucosa | 1 | 2015 | 620 | 0.080 |
Why?
| | Colorado | 2 | 2019 | 4555 | 0.080 |
Why?
| | Esophagus | 2 | 2024 | 257 | 0.080 |
Why?
| | Survival Rate | 1 | 2014 | 1935 | 0.080 |
Why?
| | Follow-Up Studies | 2 | 2019 | 5112 | 0.070 |
Why?
| | Body Mass Index | 1 | 2017 | 2349 | 0.070 |
Why?
| | Algorithms | 1 | 2015 | 1740 | 0.070 |
Why?
| | Time Factors | 2 | 2019 | 6851 | 0.070 |
Why?
| | Quality Improvement | 1 | 2016 | 1213 | 0.070 |
Why?
| | Feasibility Studies | 2 | 2021 | 980 | 0.060 |
Why?
| | Sex Factors | 1 | 2012 | 2044 | 0.060 |
Why?
| | Biopsy | 2 | 2019 | 1072 | 0.050 |
Why?
| | Calreticulin | 1 | 2022 | 28 | 0.050 |
Why?
| | HMGB Proteins | 1 | 2022 | 17 | 0.050 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2022 | 36 | 0.050 |
Why?
| | Risk Factors | 1 | 2016 | 10252 | 0.050 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2022 | 88 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2024 | 412 | 0.050 |
Why?
| | Aspergillus fumigatus | 1 | 2021 | 25 | 0.050 |
Why?
| | Lung Volume Measurements | 1 | 2021 | 47 | 0.040 |
Why?
| | Patient Compliance | 1 | 2025 | 598 | 0.040 |
Why?
| | Leptin | 1 | 2022 | 242 | 0.040 |
Why?
| | Needles | 1 | 2020 | 62 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2020 | 208 | 0.040 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 325 | 0.040 |
Why?
| | Positive-Pressure Respiration | 1 | 2020 | 104 | 0.040 |
Why?
| | Printing, Three-Dimensional | 1 | 2020 | 90 | 0.040 |
Why?
| | Pressure | 1 | 2020 | 228 | 0.040 |
Why?
| | Noninvasive Ventilation | 1 | 2020 | 56 | 0.040 |
Why?
| | Feeding Behavior | 1 | 2025 | 674 | 0.040 |
Why?
| | Speech-Language Pathology | 1 | 2019 | 23 | 0.040 |
Why?
| | Pseudomonas aeruginosa | 1 | 2021 | 348 | 0.040 |
Why?
| | Fluoroscopy | 1 | 2019 | 166 | 0.040 |
Why?
| | Social Support | 1 | 2023 | 625 | 0.040 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2022 | 335 | 0.040 |
Why?
| | Pulmonary Medicine | 1 | 2019 | 82 | 0.040 |
Why?
| | Bronchioles | 1 | 2018 | 23 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2023 | 1949 | 0.030 |
Why?
| | Efficiency, Organizational | 1 | 2019 | 138 | 0.030 |
Why?
| | Interdisciplinary Research | 1 | 2018 | 26 | 0.030 |
Why?
| | Emotions | 1 | 2023 | 568 | 0.030 |
Why?
| | Rare Diseases | 1 | 2018 | 107 | 0.030 |
Why?
| | Proteome | 1 | 2022 | 469 | 0.030 |
Why?
| | Otolaryngology | 1 | 2019 | 98 | 0.030 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 116 | 0.030 |
Why?
| | Lipids | 1 | 2022 | 675 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2025 | 2851 | 0.030 |
Why?
| | Anesthetics | 1 | 2018 | 98 | 0.030 |
Why?
| | Endoscopy | 1 | 2019 | 320 | 0.030 |
Why?
| | Perioperative Care | 1 | 2018 | 213 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2018 | 243 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 1084 | 0.030 |
Why?
| | Pilot Projects | 1 | 2021 | 1765 | 0.030 |
Why?
| | Health Services Research | 1 | 2018 | 406 | 0.030 |
Why?
| | Mouth | 1 | 2015 | 87 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 1034 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 622 | 0.030 |
Why?
| | Program Evaluation | 1 | 2019 | 916 | 0.030 |
Why?
| | Respiratory Aspiration | 1 | 2014 | 31 | 0.030 |
Why?
| | Animals | 1 | 2016 | 37217 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2019 | 654 | 0.030 |
Why?
| | Patient Outcome Assessment | 1 | 2014 | 131 | 0.030 |
Why?
| | Research Design | 1 | 2019 | 1118 | 0.020 |
Why?
| | Middle Aged | 1 | 2014 | 33604 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2023 | 5803 | 0.020 |
Why?
| | Respiratory Tract Infections | 1 | 2014 | 383 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 10923 | 0.010 |
Why?
|
|
DeBoer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|